Detalhe da pesquisa
1.
Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia.
N Engl J Med
; 389(15): 1390-1401, 2023 Oct 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37754204
2.
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions.
Clin Infect Dis
; 78(2): 248-258, 2024 02 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37738153
3.
Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens.
Antimicrob Agents Chemother
; 68(4): e0140023, 2024 Apr 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38415667
4.
Saliva screening of health care workers for SARS-CoV-2 detection.
Rev Argent Microbiol
; 54(4): 309-313, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35644767
5.
Characteristics of Patients Co-infected with Severe Acute Respiratory Syndrome Coronavirus 2 and Dengue Virus, Buenos Aires, Argentina, March-June 2020.
Emerg Infect Dis
; 27(2): 348-351, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33347804
6.
Self-collected saliva for SARS-CoV-2 detection: A prospective study in the emergency room.
J Med Virol
; 93(5): 3268-3272, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33527375
7.
Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
Clin Infect Dis
; 64(suppl_1): S30-S35, 2017 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28350901
8.
Potential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureus.
Clin Infect Dis
; 60(5): 787-96, 2015 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25472944
9.
Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality.
Clin Infect Dis
; 61 Suppl 2: S87-93, 2015 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26316562
10.
Telavancin for Acute Bacterial Skin and Skin Structure Infections, a Post Hoc Analysis of the Phase 3 ATLAS Trials in Light of the 2013 FDA Guidance.
Antimicrob Agents Chemother
; 59(10): 6170-4, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26248356
11.
Methicillin-resistant Staphylococcus aureus: an evolving pathogen.
Clin Infect Dis
; 58 Suppl 1: S10-9, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24343827
12.
Telavancin for hospital-acquired pneumonia: clinical response and 28-day survival.
Antimicrob Agents Chemother
; 58(4): 2030-7, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24419353
13.
Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies.
BMC Infect Dis
; 14: 183, 2014 Apr 04.
Artigo
Inglês
| MEDLINE | ID: mdl-24708675
14.
A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study.
BMC Infect Dis
; 14: 289, 2014 May 23.
Artigo
Inglês
| MEDLINE | ID: mdl-24884578
15.
Shedding of infectious SARS-CoV-2 in two asymptomatic children.
Medicina (B Aires)
; 83(2): 185-189, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37094186
16.
[Comparative analysis of clinical characteristics, evolution and mortality of hospitalized patients with COVID-19 during the first and second wave of the pandemic (ECCOVID Study)]. / Análisis comparativo de las características clínicas, evolución y mortalidad de pacientes hospitalizados por COVID-19 durante la primera y segunda ola de la pandemia (Registro ECCOVID).
Medicina (B Aires)
; 83(4): 551-557, 2023.
Artigo
Espanhol
| MEDLINE | ID: mdl-37582129
17.
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.
Lancet Microbe
; 4(3): e159-e170, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36774938
18.
TD-1792 versus vancomycin for treatment of complicated skin and skin structure infections.
Antimicrob Agents Chemother
; 56(11): 5476-83, 2012 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-22869571
19.
Efficacy of telavancin in patients with specific types of complicated skin and skin structure infections.
J Antimicrob Chemother
; 67(6): 1496-502, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-22416054
20.
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.
Lancet Infect Dis
; 22(3): 401-412, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34767753